设为首页收藏本站

中国病毒学论坛|我们一直在努力!

 找回密码
 立即注册

QQ登录

只需一步,快速开始

搜索
热搜: 活动 交友 discuz

Springer电子书:Development of Novel Vaccines

发布者: douban | 发布时间: 2016-8-27 11:57| 查看数: 926| 评论数: 18|帖子模式

本帖最后由 douban 于 2016-8-27 12:00 编辑
3 H* f4 D  n- T- q8 d: _3 t
# B( R) m  y1 H" @" o( @4 Q1 Z" NDevelopment of Novel Vaccines! I) j; B, x) H
% [7 L5 U% p' {# q1 v9 T4 z0 G; d
Skills, Knowledge and Translational Technologies
# T6 ]5 Y8 B$ T2 E4 J2 V
5 }! m; |. c2 a2 b2 t+ KEditors: von Gabain, Alexander, Klade, Christoph (Eds.) ( `. t+ j/ V2 ], u" Q; Z" O

6 t7 ?0 m6 l5 N! M5 R  y" `3 M  E+ r6 ]% B* O% N9 [( [

  T2 P* l3 L/ ^& Z5 Y. ZAbout this book8 Y/ W1 ~: B9 P7 V" ^/ P
# ?) ^' C, \8 I) M: |5 i1 L
“Development of novel vaccines” gives an overview of the tasks in basic research leading to the final product – the vaccine and its applications, belonging to the most complex biologics in the pharmaceutical field. Distinct from most textbooks in the vaccine arena, the current issue focuses on the translational aspect, namely, how research results can be transformed into life-saving medical interventions.  Each chapter of the book deals with one important paradigm for the development of novel vaccines, along the value chain towards the final vaccine, and furthermore, with the inevitable tools required for this process. Contributions are prepared by teams of scientists, all of whom are experts in the field, most of them anchored in biomedical organizations devoted to translational culture, thereby lighting the certain topics from different views. This volume is a must read for researchers engaged in vaccine development and who really want to see their research results to become a product.; O! k7 X: {& h1 D# t2 q2 S
7 p4 G1 w! g: k5 V4 M7 Y3 s% x* ]! q
' J& B- K8 J: Q1 `4 h
Table of contents (11 chapters)
) w' \# J; ?' x+ B; ]3 n: J0 E! v8 d6 b

+ a7 J( R6 E6 Q/ q+ Y' P  gSkills, Knowledge, and Translational Technologies Leading to Novel Vaccines2 _2 T$ Z8 @" p2 z% R" u

0 f" o) H7 {2 F9 AAlkan, Şefik Ş.8 X4 @1 }8 o2 z2 M8 B5 X, F
0 ~# M9 n2 J0 Q
Pages 1-267 e6 k; H6 d  Y2 [! i0 |1 r
' N  L& j" S: h: L% B% [% `0 Y8 I. d
Finding Protective Bacterial Antigens
# w! r- Q  [! ~8 b0 L. l2 g3 D0 a: q. ^9 o" ~! p
Grandi, Guido (et al.): J0 z- m9 Z( [

3 E" E5 R/ D0 d( Z. n2 wPages 27-44
3 s9 e# e1 F. s- I! Z; |
/ y6 ?' f' z0 c: m* ~9 v/ l, U0 Y( n8 u
Enhancing and Tailoring the Immunogenicity of Vaccines with Novel Adjuvants
& T0 q4 d/ B# F3 e, e6 W. V5 o" d9 N
Fox, Christopher B. (et al.): q& f3 B/ j2 z3 m: @2 h9 n

, j; Q) @5 m1 u" l  uPages 45-720 D& Y0 }& G7 ?3 I  n6 k! v

8 a) r9 Z: o$ X5 x( B7 W  \7 ]: a
6 u+ G$ }( _" \4 J7 P" i* D! w1 r$ z' ~! u3 L7 A, @( u: v6 c
Vaccine Delivery: Beyond Needles  e0 C0 j% l7 n1 }
: _7 q! t7 ?) X. h
Flyer, David C. (et al.)7 ?& B# \& v! T- w- L

- |- c3 {; g. K) {! h, APages 73-86' p, U% Y8 ^7 W
' R/ G) z1 \! l5 M
" q: T* T* ]4 Y3 Q& Y

' a/ V' M) H; g& U5 t! F: r3 GEmploying Live Microbes for Vaccine Delivery8 }4 s4 `  W" j" x8 X1 \
0 O6 r8 T& p" ^7 l% k3 z( a
Loessner, Holger (et al.)3 E$ E/ B. H! _
& y/ P+ i) o8 B! B
Pages 87-124% m: e  k' C4 a" p! O7 Z5 ^  i! l  U

2 Z# `7 x& {! C, e8 g
! l; ?( G' Z1 H% [9 X" U$ I! Q. M6 L3 ^+ u9 M. }/ q
Synthesizing Vaccines with Microbes- R; C& N& a* @, Z
- ]' I1 A; k  r: @/ Q
Wacker, Michael (et al.)
; e4 Z# g$ h! `/ Y& j9 T% ^! B) a, S9 _0 v* j
Pages 125-144! _, k8 L" s( @

4 d# y; g( q8 P" n1 ^! r- O5 s! i
# @8 f( x0 P; W# C$ I6 o
Purification and Formulation: Silent but Important Players in Vaccine Development
! y- E5 _0 ^2 _+ \) P; w' t- U* f1 Y- ^7 H
Schlegl, Robert (et al.)/ L- C- n5 }0 S# m, \/ K, Z

8 E/ G6 `. P3 ~( ~/ v* cPages 145-1884 D8 v- w( ?7 F9 x, g& e
/ k2 E) H& o; a. W4 R9 d! j

; C" p. Z' S# n- W7 j( ]% U& C7 i+ ?& d  t4 F8 P+ L  H. }
Cutting-Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines. B8 R4 W# `$ R! D  `' |

% Q& O  z: X& c! NArnon, Ruth (et al.)/ Z# H5 {9 |* O$ J2 @" q/ v
( o% ?2 f) o+ k  X- _, f1 U1 ?
Pages 189-204. g7 b2 L9 j+ o( r) P1 l, {8 ~
2 H0 ]* B$ S3 d8 F  S
5 U6 A+ B4 D9 }+ u* W: O! W

% l' u- _; _" c( |8 tCutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines
9 e9 a* W  x, l9 K, y
& |+ t+ F4 B+ d5 H$ G( D% f5 gRoose, Kenny (et al.), R9 Y1 j8 u) O: _+ ^* i2 R

5 K/ G; M$ l) Y2 M7 \! b0 PPages 205-232
& U1 ]$ I! s* _/ T2 `' a8 s4 A; q4 |2 K6 e: E) `4 E5 L3 p
8 R  ?3 T0 w# }
, I; D5 t; o% ]6 W- W8 W4 f0 g' }! v
Examples of Novel Registered Prophylactic Vaccines, HPV, and JEV4 t/ V/ @2 x8 V" \! I/ t5 ]1 d

; l( {+ }( b) }$ V7 C# |Dubischar-Kastner, Katrin (et al.)3 v; O4 h5 C( e0 C. \' l2 ^, q4 m

/ j( A- n7 X2 [/ F% D) w& G2 bPages 233-286
% b  S# r% f  v5 n" G
& Z7 w" F5 q' O3 w# Q7 U
. z. E$ N1 d( P5 l0 @4 P. C1 f4 t5 e
The Bumpy Road Toward Vaccine Registration: How to Overcome Regulatory Hurdles" r' P: C8 _7 I# h3 Y
2 M% N9 V. M& E/ }5 w
Pfleiderer, Michael' D# _7 ^  ?3 a6 r8 E: G% k4 y

7 q5 m" |8 w# m" uPages 287-300
- D: |3 _& J( d
7 Y9 Z4 I) J; s- h下载链接:" s5 Y/ B3 f7 ]: P/ n7 B& j
游客,如果您要查看本帖隐藏内容请回复
/ H* M1 r' p, d- y8 }3 a3 R2 {

本帖子中包含更多资源

您需要 登录 才可以下载或查看,没有帐号?立即注册

x

评分

参与人数 1学分 +5 金币 +500 收起 理由
ipsvirus + 5 + 500 很给力!

查看全部评分

最新评论

Biodog 发表于 2016-8-27 12:54:55
感谢分享
& Z8 f  f, R( Y" R1 L! _: z- b4 D
hydwangyong 发表于 2016-8-29 07:53:49
谢谢分享
borntotry1 发表于 2016-9-23 09:25:54
正是需要的
borntotry1 发表于 2016-9-23 09:26:20
正是我需要的,谢谢分享
chenzongxiang 发表于 2016-10-9 10:33:39
谢谢分享,好好学习!
序道 发表于 2016-10-9 10:54:11
学习学习下
freud1981213 发表于 2016-11-16 22:38:32
a good book
freud1981213 发表于 2016-11-16 22:39:05
无法下载??
序道 发表于 2016-11-21 21:25:04
不错
7 T  W5 J) p, C' K4 _
12下一页

QQ|论坛App下载|Archiver|小黑屋|中国病毒学论坛    

GMT+8, 2018-4-27 08:44 , Processed in 0.247840 second(s), 35 queries .

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表